GlassScriptPhysician profile
Leah K Bell
NPI 1245735042
$1,212.05
in general payments reported to CMS, 2019-2025
25 companies · $474 in 2025
The $474 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.87 · 2023: $298 · 2024: $378 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $253.64 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $206.21 | 2022-2025 | |
| Dexcom, INC. | $144.51 | 2024-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $90.37 | 2023-2025 | Myfembree |
| Abbvie INC. | $71.94 | 2023-2025 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $44.61 | 2022-2025 | Jada System, Nexplanon |
| Shield Therapeutics INC | $40.38 | 2023-2024 | Accrufer |
| Daiichi Sankyo INC. | $39.47 | 2023 | Injectafer |
| Lsi Solutions INC | $30.73 | 2025 | Fornisee |
| Innovation Technologies INC | $29.75 | 2025 | Irrisept |
| Exeltis, USA INC. | $28.35 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $25.79 | 2023 | |
| Coopersurgical, INC. | $23.15 | 2025 | Paragard T 380a |
| Heron Therapeutics, INC. | $21.34 | 2023 | Zynrelef |
| Olympus America INC. | $16.46 | 2024 | Olympus |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.14 | 2024 | Zepbound |
| Baxter Healthcare | $15.84 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $15.83 | 2023 | Belsomra |
| Agile Therapeutics, INC. | $14.74 | 2023 | Twirla |
| Glaxosmithkline, LLC. | $14.49 | 2024 | Bexsero |
| Exact Sciences Corporation | $14.35 | 2023 | Cologuard Collection Kit |
| Vivus LLC | $14.29 | 2024 | Qsymia |
| Davol INC. | $13.45 | 2023 | Arista Ah Flexitip |
| Pfizer INC. | $13.39 | 2023 | |
| Novo Nordisk INC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.